About IDROFOS IBANDRONIC ACID TABLETS
Idrofos Tablets
Specifications:-
- Strength:150 mg
- Form:Tablet
- Manufacturer:SUN Pharma
- Brand:IDROFOS
- Packaging Size:pack of 1x3 tablets
- Composition:Ibandronic Acid
Note :- IDROFOS Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............
Effective Osteoporosis Management for WomenIdrofos Tablets are tailored for the treatment and prevention of osteoporosis in postmenopausal women. By increasing bone mineral density, it reduces the risk of fractures and strengthens overall bone health. This medication is prescribed for adults and offers a reliable solution for individuals seeking to maintain bone strength during menopause.
Simple Dosage Guidelines for Safe UsageFor optimal absorption and reduced side effects, Idrofos should be taken orally on an empty stomach with a full glass of water. Patients must remain upright for at least 60 minutes post-administration. Adherence to these guidelines ensures effective delivery of the active ingredient and minimizes gastrointestinal discomfort.
Stringent Quality and Safety StandardsIdrofos is manufactured under WHO-GMP certified conditions, guaranteeing its quality and purity. The product is distributed, exported, and supplied across India by reputable sources, making it accessible to healthcare providers and patients. Each box contains 10 tablets, ensuring a manageable supply for prescribed treatment durations.
FAQs of IDROFOS IBANDRONIC ACID TABLETS:
Q: How should Idrofos Ibandronic Acid Tablets be taken for best results?
A: Idrofos tablets should be taken orally on an empty stomach with a full glass of water. After taking the tablet, remain upright for at least 60 minutes to enhance absorption and reduce gastrointestinal side effects.
Q: What is the therapeutic benefit of Idrofos Tablets?
A: Idrofos helps prevent and treat osteoporosis by increasing bone mineral density, particularly in postmenopausal women. This leads to stronger bones and a reduced risk of fractures.
Q: When is Idrofos contraindicated for use?
A: Idrofos should not be used in patients with severe renal impairment or hypocalcemia. Always consult a physician to ensure suitability before starting this medication.
Q: Where should Idrofos Tablets be stored?
A: Store Idrofos in a cool, dry place below 30C. Keep the tablets protected from light and moisture to maintain their effectiveness throughout the shelf life.
Q: What side effects can occur while using Idrofos Tablets?
A: Possible side effects include abdominal pain, dyspepsia (indigestion), nausea, and musculoskeletal pain. If you experience severe or persistent symptoms, seek medical advice promptly.
Q: Who is Idrofos recommended for?
A: Idrofos is primarily recommended for adults with osteoporosis, especially postmenopausal women, as part of a physician-guided treatment regimen.
Q: What process does Idrofos follow to improve bone health?
A: Idrofos contains Ibandronic Acid, which acts as a bisphosphonate. It works by slowing bone loss and enhancing bone mineral density, effectively helping to manage osteoporosis.